ConductScience.org, home

Paper42579188

Stem-like characteristics across sequentially temozolomide-adapted glioblastoma cell populations with increasing levels of acquired resistance.

Sari DH and 3 others. Mol Biol Rep, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Stem-like characteristics across sequentially temozolomide-adapted glioblastoma cell populations with increasing levels of acquired resistance. Papers, record 42579188. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42579188

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Stem-like characteristics across sequentially temozolomide-adapted glioblastoma cell populations with increasing levels of acquired resistance.
PubMed
Journal
Mol Biol Rep
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-11-05
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sari DHDewi Hambar
2Wanandi SISeptelia Inawati
3Aman RARenindra Ananda
4Kasim VVivi

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
TemozolomideMajor topic
GlioblastomaMajor topic
Drug Resistance, NeoplasmMajor topic
Neoplastic Stem CellsMajor topic
Humans
Cell Line, Tumor
Cell Proliferation
Vimentin
Antineoplastic Agents, Alkylating
SOXB1 Transcription Factors
Gene Expression Regulation, Neoplastic
Octamer Transcription Factor-3
Brain Neoplasms
AC133 Antigen
Matrix Metalloproteinase 2

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
PUTI Q2 Research Grant (Number: NKB-651/UN2.RST/HKP.05.00/2024)Direktorat Riset and Pengembangan, Universitas IndonesiaPubMed
PUTI Q2 Research Grant (Number: NKB-651/UN2.RST/HKP.05.00/2024)Direktorat Riset and Pengembangan, Universitas IndonesiaPubMed
PUTI Q2 Research Grant (Number: NKB-651/UN2.RST/HKP.05.00/2024)Direktorat Riset and Pengembangan, Universitas IndonesiaPubMed
PUTI Q2 Research Grant (Number: NKB-651/UN2.RST/HKP.05.00/2024)Direktorat Riset and Pengembangan, Universitas IndonesiaPubMed

Source PubMed

Download CSV of grants

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126314899Dissecting the role of distinct OCT4-SOX2 heterodimer configurations in pluripotency.Sci Rep2015https://conductscience.org/library/papers/26314899PubMed
227109183Nogo-A inhibits the migration and invasion of human malignant glioma U87MG cells.Oncol Rep2016https://conductscience.org/library/papers/27109183PubMed
334337348Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review.Cancer Drug Resist2021https://conductscience.org/library/papers/34337348PubMed
438329598Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance.Cancer Metastasis Rev2024https://conductscience.org/library/papers/38329598PubMed
533614649Temozolomide Treatment Induces HMGB1 to Promote the Formation of Glioma Stem Cells via the TLR2/NEAT1/Wnt Pathway in Glioblastoma.Front Cell Dev Biol2021https://conductscience.org/library/papers/33614649PubMed
640461793Acquired resistance in cancer: towards targeted therapeutic strategies.Nat Rev Cancer2025https://conductscience.org/library/papers/40461793PubMed
740346362Deciphering the longitudinal trajectories of glioblastoma ecosystems by integrative single-cell genomics.Nat Genet2025https://conductscience.org/library/papers/40346362PubMed
830999923OCT4 and PAX6 determine the dual function of SOX2 in human ESCs as a key pluripotent or neural factor.Stem Cell Res Ther2019https://conductscience.org/library/papers/30999923PubMed
931907355Identification of a transient state during the acquisition of temozolomide resistance in glioblastoma.Cell Death Dis2020https://conductscience.org/library/papers/31907355PubMed
1034427324Brain and other central nervous system tumor statistics, 2021.CA Cancer J Clin2021https://conductscience.org/library/papers/34427324PubMed
1135274101Expression of pluripotency-related genes in human glioblastoma.Neurooncol Adv2022https://conductscience.org/library/papers/35274101PubMed
1234932099Cancer cell heterogeneity and plasticity: A paradigm shift in glioblastoma.Neuro Oncol2022https://conductscience.org/library/papers/34932099PubMed
1338158149Mitochondrial Mechanisms in Temozolomide Resistance: Unraveling the Complex Interplay and Therapeutic Strategies in Glioblastoma.Mitochondrion2024https://conductscience.org/library/papers/38158149PubMed
1439589998Recapitulating Glioma Stem Cell Niches Using 3D Spheroid Models for Glioblastoma Research.Biosensors (Basel)2024https://conductscience.org/library/papers/39589998PubMed
1535710946Brain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneity.Nat Rev Cancer2022https://conductscience.org/library/papers/35710946PubMed
1637444568Emerging Role of Glioma Stem Cells in Mechanisms of Therapy Resistance.Cancers (Basel)2023https://conductscience.org/library/papers/37444568PubMed
1741102523CRISPR screen reveals SOX2 as a critical regulator of CD133 and cellular stress response in glioblastoma.Sci Rep2025https://conductscience.org/library/papers/41102523PubMed
1841013839Cancer cell plasticity and therapeutic resistance: mechanisms, crosstalk, and translational perspectives.Hereditas2025https://conductscience.org/library/papers/41013839PubMed
1940468460Overcoming temozolomide resistance in glioma: recent advances and mechanistic insights.Acta Neuropathol Commun2025https://conductscience.org/library/papers/40468460PubMed
2040253386Temozolomide promotes glioblastoma stemness expression through senescence-associated reprogramming via HIF1α/HIF2α regulation.Cell Death Dis2025https://conductscience.org/library/papers/40253386PubMed

See all 38 referencesDownload CSV of references

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
MMP24313PubTator's text mininghttps://conductscience.org/library/genes/4313NCBI Gene
POU5F15460PubTator's text mininghttps://conductscience.org/library/genes/5460NCBI Gene
PROM18842PubTator's text mininghttps://conductscience.org/library/genes/8842NCBI Gene
SOX26657PubTator's text mininghttps://conductscience.org/library/genes/6657NCBI Gene
VIM7431PubTator's text mininghttps://conductscience.org/library/genes/7431NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42579188

GET https://conductscience.org/api/papers/v1/42579188/references?page=2